刘新泳山东大学主页平台管理系统--中文主页

论文成果

[371] 展鹏 , 刘新泳 and 康东伟. Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse .... 《Journal of Medicinal Chemistry》, 62, 1484, 2019.
[372] 展鹏 , 刘新泳 and 黄伯世. Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Bi.... 《Journal of Medicinal Chemistry》, 62, 2083, 2019.
[373] 展鹏 , 刘新泳 and 汪昭. Design, synthesis, and antiviral evaluation of novel hydrazone-substituted thiophene[3,2-d]pyrimi.... Chemical Biology & Drug Design, 92, 2009, 2018.
[374] 展鹏 , 刘新泳 and 张健. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A .... Journal of Medicinal Chemistry, 61, 9976, 2018.
[375] 展鹏 , 刘新泳 and 鞠翰. Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolut.... Future Medicinal Chemistry, 11, 265, 2019.
[376] 刘新泳 and 展鹏. Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Ca.... 《Journal of Medicinal Chemistry》, 62, 3251, 2019.
[377] 展鹏 , 刘新泳 and 黄伯世. Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybr.... Bioorganic & medicinal chemistry, 25, 4397, 2017.
[378] 展鹏 , 刘新泳 and 孟青. The development of an effective synthetic route of lesinurad (RDEA594). Chemistry Central Journal, 11, 2017.
[379] 刘新泳 and 展鹏. Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016). Recent Patents on Anti-Cancer Drug Discovery, 12, 16, 2017.
[380] 展鹏 , 刘新泳 and 程锡强. Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 int.... Expert Opinion on Therapeutic Patents, 27, 1277, 2017.

共563条 38/57

首页上页下页尾页页

刘新泳

教授

性别：男

在职信息：在职

所在单位：药学院

入职时间： 1991-07-01

版权所有 ©山东大学　地址：中国山东省济南市山大南路27号　邮编：250100　
查号台：（86）-0531-88395114
值班电话：（86）-0531-88364731　建设维护：山东大学信息化工作办公室　　
访问量：手机版 English 登录山东大学

最后更新时间： ..